V1 sact_regimen
730,471 rows · 12 columns
| MERGED_REGIMEN_ID | MERGED_TUMOUR_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | MERGED_PATIENT_ID | BENCHMARK_GROUP |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 310007481 | 310004620 | 1.66 | null | Curative (C) | 2014-06-24 | 2014-09-18 | Methotrexate intrathecal | N | N | 310018418 | METHOTREXATE INTRATHECAL |
| 310007482 | 310004620 | null | null | Curative (C) | 2016-01-04 | 2016-01-18 | CARBOPLATIN + ETOPOSIDE | N | N | 310018418 | BEXAROTENE |
| 310007483 | 310004620 | 1.59 | 51 | Curative (C) | 2016-10-11 | 2016-11-03 | Bevacizumab + CARBOPLATIN + PACLITAXEL | Y | null | 310018418 | CARBOPLATIN + ETOPOSIDE |
| 310007484 | 310004620 | 1.59 | null | Curative (C) | 2015-08-30 | 2015-09-06 | Rituximab | N | N | 310018418 | RITUXIMAB |
| 310007485 | 310004621 | 1.78 | 55.9 | Curative (C) | 2016-12-16 | 2016-12-19 | GDP | 2 | N | 310018440 | GDP |
| 310007486 | 310004622 | null | 90.45 | Disease modification (D) | 2017-10-30 | 2018-01-10 | CYCLOPHOSPHAMIDE | N | N | 310018446 | CYCLOPHOSPHAMIDE |
| 310007487 | 310004627 | 1.77 | null | Not known (9) | 2014-10-08 | 2014-10-19 | Bexarotene | Y | N | 310018446 | BEXAROTENE |
| 310007488 | 310004627 | null | 72.4 | Disease modification (D) | 2014-04-18 | 2014-04-18 | Etoposide oral | 02 | N | 310018446 | ETOPOSIDE |
| 310007489 | 310007968 | 1.59 | 98 | Palliative (P) | 2017-07-26 | 2017-07-26 | CYCLOPHOSPHAMIDE | N | N | 310018460 | CYCLOPHOSPHAMIDE |
| 310007490 | 310007968 | null | 78.2 | Palliative (P) | null | 2013-06-22 | Ipilimumab | 02 | null | 310018460 | IPILIMUMAB |
| 310007491 | 310007968 | 1.8 | 68.3 | Curative (C) | 2014-04-05 | 2014-04-08 | Cisplatin 100 + RT(H&N) 1 day | 2 | N | 310018460 | CISPLATIN + RT |
| 310007492 | 310007969 | 1.63 | null | null | 2013-09-04 | 2013-09-11 | Methotrexate intrathecal | N | N | 310018464 | METHOTREXATE INTRATHECAL |
| 310007493 | 310004633 | 1.57 | null | Palliative (P) | null | 2013-08-23 | CHOP R - 21 days | 02 | N | 310018466 | CHOP R |
| 310007494 | 310009757 | 1.84 | 82.2 | Adjuvant (A) | 2013-06-01 | 2013-08-27 | CYCLOPHOSPHAMIDE + FILGRASTIM | N | N | 310018467 | CYCLOPHOSPHAMIDE |
| 310007495 | 310004640 | 1.93 | 85.45 | null | 2017-07-13 | 2017-11-24 | Rituximab | N | N | 310018472 | RITUXIMAB |
| 310007496 | 310009759 | 1.84 | 99 | Palliative (P) | 2015-01-28 | 2015-01-31 | Docetaxel | N | N | 310018474 | DOCETAXEL |
| 310007497 | 310010712 | null | 50 | Palliative (P) | 2018-05-25 | 2018-05-25 | CYCLOPHOSPHAMIDE + FILGRASTIM | 2 | N | 310018476 | CYCLOPHOSPHAMIDE |
| 310007498 | 310004641 | 1.7 | null | Palliative (P) | null | 2019-01-28 | Carboplatin + Etoposide iv&po | N | N | 310018476 | BEVACIZUMAB + CARBOPLATIN + PACLITAXEL |
| 310007499 | 310004644 | 1.63 | null | Curative (C) | 2015-08-23 | 2015-09-04 | Bevacizumab+Carbo+Pacliaxel | 02 | N | 310018482 | BEVACIZUMAB + CARBO + PACLITAXEL |
| 310007500 | 310004644 | 1.58 | 77 | Palliative (P) | 2014-08-19 | 2014-08-20 | Bexarotene | N | N | 310018482 | UKALL2011 |
| 310007501 | 310004647 | 1.85 | 73 | Curative (C) | 2017-07-01 | 2017-07-18 | Bexarotene | Y | N | 310018486 | BEXAROTENE |
| 310007502 | 310007979 | 1.73 | 52.3 | Curative (C) | 2016-07-01 | 2016-07-02 | Ipilimumab | N | N | 310018495 | IPILIMUMAB |
| 310007503 | 310007979 | 1.62 | 92.9 | Palliative (P) | null | 2017-09-12 | CYCLOPHOSPHAMIDE + MESNA | Y | N | 310018495 | CYCLOPHOSPHAMIDE |
| 310007504 | 310004648 | null | 88.2 | null | 2014-09-06 | 2014-09-06 | Cyclophosphamide High Dose | N | null | 310018499 | CYCLOPHOSPHAMIDE HIGH DOSE |
| 310007505 | 310004648 | 1.53 | null | Palliative (P) | 2016-02-14 | 2016-02-20 | Docetaxel + Gemcitabine with GCSF | 02 | N | 310018499 | DOCETAXEL + GEMCITABINE |
| 310007506 | 310009764 | null | 52.4 | Not known (9) | 2018-01-27 | 2018-02-02 | CISPLATIN + RT | N | N | 310018505 | CISPLATIN + RT |
| 310007507 | 310009764 | 1.75 | 51 | null | 2018-02-13 | 2018-02-14 | Cisplatin + Radiotherapy | N | N | 310018505 | CISPLATIN + RT |
| 310007509 | 310004656 | 1.85 | 83.3 | Curative (C) | 2017-02-02 | 2017-02-23 | Methotrexate intrathecal | N | N | 310018510 | METHOTREXATE INTRATHECAL |
| 310007510 | 310004659 | 1.7 | 77 | Palliative (P) | 2017-03-30 | 2017-03-30 | BEVACIZUMAB + CARBO + PACLITAXEL | 02 | N | 310018514 | BEVACIZUMAB + CARBO + PACLITAXEL |
| 310007511 | 310009765 | 1.88 | 76.8 | Curative (C) | 2017-02-15 | 2017-02-16 | Cisplatin 100 + RT(H&N) 1 day | N | N | 310018516 | CISPLATIN + RT |
| 310007512 | 310004660 | 1.74 | 96.5 | Palliative (P) | 2014-07-02 | 2014-07-08 | Ipilimumab | 2 | N | 310018518 | IPILIMUMAB |
| 310007513 | 310004660 | 1.54 | 51.6 | null | 2014-05-27 | 2014-05-28 | CYCLOPHOSPHAMIDE + ETOPOSIDE + Procarbazine | N | N | 310018518 | CYCLOPHOSPHAMIDE + ETOPOSIDE + PROCARBAZINE |
| 310007514 | 310004661 | null | null | Palliative (P) | 2017-09-18 | 2018-01-09 | Bevacizumab + CARBOPLATIN + PACLITAXEL | 2 | N | 310018522 | BEVACIZUMAB + CARBOPLATIN + PACLITAXEL |
| 310007515 | 310004661 | 1.7 | 79.4 | Palliative (P) | 2018-02-02 | 2018-02-27 | Bexarotene | N | null | 310018522 | BEVACIZUMAB + CARBOPLATIN + PACLITAXEL |
| 310007516 | 310004661 | null | 84.4 | Curative (C) | 2014-01-23 | 2014-01-23 | ESHAP | 2 | N | 310018522 | CARBOPLATIN + ETOPOSIDE |
| 310007517 | 310004661 | null | 66 | null | 2013-11-24 | 2013-11-24 | CYCLOPHOSPHAMIDE + ETOPOSIDE + Procarbazine | N | null | 310018522 | CYCLOPHOSPHAMIDE + ETOPOSIDE + PROCARBAZINE |
| 310007518 | 310004664 | 1.66 | 96 | Palliative (P) | 2017-05-02 | 2017-05-02 | Docetaxel | 2 | N | 310018530 | DOCETAXEL |
| 310007519 | 310004666 | 1.49 | 96 | null | 2017-10-03 | 2017-12-20 | Etoposide oral | N | N | 310018530 | ETOPOSIDE |
| 310007520 | 310004667 | 1.8 | 79 | Curative (C) | 2017-01-29 | 2017-02-02 | BEVACIZUMAB + CARBO + PACLITAXEL | 02 | N | 310018536 | BEVACIZUMAB + CARBO + PACLITAXEL |
| 310007521 | 310004668 | 1.71 | null | Palliative (P) | 2018-03-31 | 2018-03-31 | Cyclophosphamide oral | N | N | 310018537 | CYCLOPHOSPHAMIDE |
| 310007522 | 310004673 | 1.57 | 75.9 | Palliative (P) | 2017-04-08 | 2017-06-05 | BEVACIZUMAB + CARBO + PACLITAXEL | 02 | N | 310018548 | BEVACIZUMAB + CARBO + PACLITAXEL |
| 310007524 | 310004677 | 1.78 | 77.2 | Adjuvant (A) | 2016-10-23 | 2016-11-13 | ESHAP | N | N | 310018553 | CARBOPLATIN + ETOPOSIDE |
| 310007525 | 310004677 | 1.62 | 106 | Curative (C) | 2014-03-15 | 2014-06-15 | Cisplatin | 02 | N | 310018553 | CISPLATIN |
| 310007526 | 310009769 | 1.6 | 76.5 | Curative (C) | 2016-02-28 | 2016-02-28 | Cisplatin 100 + RT(H&N) 1 day | N | N | 310018568 | CISPLATIN + RT |
| 310007527 | 310004680 | 1.78 | 91.7 | Palliative (P) | 2015-03-19 | 2015-09-12 | BEVACIZUMAB + CARBO + PACLITAXEL | 2 | N | 310018574 | BEVACIZUMAB + CARBO + PACLITAXEL |
| 310007528 | 310004682 | 1.6 | null | Curative (C) | 2016-09-21 | 2016-11-03 | Methotrexate intrathecal | 02 | N | 310018576 | METHOTREXATE INTRATHECAL |
| 310007529 | 310004683 | 1.7 | null | Palliative (P) | 2016-11-26 | 2016-12-06 | Docetaxel + Gemcitabine with GCSF | 02 | N | 310018582 | DOCETAXEL + GEMCITABINE |
| 310007530 | 310004684 | 1.63 | 88.1 | Disease modification (D) | 2016-06-07 | 2016-07-20 | Cisplatin | Y | Y | 310018582 | CISPLATIN |
| 310007531 | 310004685 | 1.79 | 50 | Palliative (P) | 2014-11-19 | 2014-11-20 | CYCLOPHOSPHAMIDE + ETOPOSIDE + Procarbazine | 02 | N | 310018584 | CYCLOPHOSPHAMIDE + ETOPOSIDE + PROCARBAZINE |
| 310007532 | 310004686 | null | 53.6 | Palliative (P) | 2013-10-12 | 2014-01-10 | Bevacizumab + CARBOPLATIN + PACLITAXEL | 02 | N | 310018584 | ESHAP |